A detailed history of Petrus Trust Company, Lta transactions in Merck & Co., Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 4,854 shares of MRK stock, worth $479,672. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,854
Previous 2,454 97.8%
Holding current value
$479,672
Previous $303,000 81.85%
% of portfolio
0.06%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $266,760 - $309,528
2,400 Added 97.8%
4,854 $551,000
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $355,233 - $413,927
-3,137 Reduced 56.11%
2,454 $323,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $560,106 - $609,530
5,591 New
5,591 $609,000
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $149,846 - $207,694
-2,365 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $183,476 - $207,032
2,365 New
2,365 $215,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.